Generation Bio (GBIO) Competitors $4.21 -0.23 (-5.18%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$4.22 +0.00 (+0.12%) As of 08/1/2025 06:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GBIO vs. ALTS, CNTB, FTLF, SKYE, CHRS, PLX, CRDL, SAVA, CRBP, and ZURAShould you be buying Generation Bio stock or one of its competitors? The main competitors of Generation Bio include ALT5 Sigma (ALTS), Connect Biopharma (CNTB), FitLife Brands (FTLF), Skye Bioscience (SKYE), Coherus Oncology (CHRS), Protalix BioTherapeutics (PLX), Cardiol Therapeutics (CRDL), Cassava Sciences (SAVA), Corbus Pharmaceuticals (CRBP), and Zura Bio (ZURA). These companies are all part of the "pharmaceutical products" industry. Generation Bio vs. Its Competitors ALT5 Sigma Connect Biopharma FitLife Brands Skye Bioscience Coherus Oncology Protalix BioTherapeutics Cardiol Therapeutics Cassava Sciences Corbus Pharmaceuticals Zura Bio ALT5 Sigma (NASDAQ:ALTS) and Generation Bio (NASDAQ:GBIO) are both small-cap pharmaceutical products companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, earnings, media sentiment, institutional ownership and risk. Is ALTS or GBIO more profitable? ALT5 Sigma has a net margin of -38.58% compared to Generation Bio's net margin of -292.92%. Generation Bio's return on equity of -75.84% beat ALT5 Sigma's return on equity.Company Net Margins Return on Equity Return on Assets ALT5 Sigma-38.58% -113.79% -8.96% Generation Bio -292.92%-75.84%-30.40% Which has more volatility & risk, ALTS or GBIO? ALT5 Sigma has a beta of 2.17, suggesting that its share price is 117% more volatile than the S&P 500. Comparatively, Generation Bio has a beta of 2.67, suggesting that its share price is 167% more volatile than the S&P 500. Do institutionals & insiders believe in ALTS or GBIO? 6.3% of ALT5 Sigma shares are owned by institutional investors. Comparatively, 95.2% of Generation Bio shares are owned by institutional investors. 4.9% of ALT5 Sigma shares are owned by company insiders. Comparatively, 21.8% of Generation Bio shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has preferable valuation and earnings, ALTS or GBIO? ALT5 Sigma has higher earnings, but lower revenue than Generation Bio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioALT5 Sigma$12.53M8.75-$6.24MN/AN/AGeneration Bio$19.89M1.42-$131.67M-$10.80-0.39 Does the media refer more to ALTS or GBIO? In the previous week, Generation Bio had 1 more articles in the media than ALT5 Sigma. MarketBeat recorded 1 mentions for Generation Bio and 0 mentions for ALT5 Sigma. ALT5 Sigma's average media sentiment score of 0.00 beat Generation Bio's score of -0.63 indicating that ALT5 Sigma is being referred to more favorably in the media. Company Overall Sentiment ALT5 Sigma Neutral Generation Bio Negative Do analysts rate ALTS or GBIO? Generation Bio has a consensus price target of $80.00, indicating a potential upside of 1,800.24%. Given Generation Bio's stronger consensus rating and higher possible upside, analysts plainly believe Generation Bio is more favorable than ALT5 Sigma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ALT5 Sigma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Generation Bio 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryGeneration Bio beats ALT5 Sigma on 9 of the 14 factors compared between the two stocks. Get Generation Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for GBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GBIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GBIO vs. The Competition Export to ExcelMetricGeneration BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$29.76M$3.00B$5.49B$9.54BDividend YieldN/A2.43%4.73%4.09%P/E Ratio-0.3917.7428.8323.83Price / Sales1.42179.21372.0766.02Price / CashN/A41.9535.4557.96Price / Book0.338.508.275.54Net Income-$131.67M-$55.06M$3.25B$259.28M7 Day Performance-8.68%-3.99%-3.73%-4.68%1 Month Performance24.59%9.58%4.29%4.36%1 Year Performance-85.82%6.70%25.87%17.88% Generation Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GBIOGeneration Bio3.7081 of 5 stars$4.21-5.2%$80.00+1,800.2%-86.7%$29.76M$19.89M-0.39150Upcoming EarningsGap DownALTSALT5 SigmaN/A$6.98-1.4%N/A+302.6%$123.58M$12.53M0.00170CNTBConnect Biopharma2.6328 of 5 stars$2.08-6.3%$7.00+236.5%+73.9%$123.35M$26.03M0.00110Short Interest ↑FTLFFitLife Brands3.5497 of 5 stars$12.83-0.5%$20.50+59.8%-22.0%$121.15M$63.86M15.2720News CoveragePositive NewsSKYESkye Bioscience1.4692 of 5 stars$3.74-4.3%$16.60+343.9%-37.8%$121.11MN/A-4.5611Gap DownCHRSCoherus Oncology3.8057 of 5 stars$1.07+2.9%$4.68+337.7%-38.6%$120.57M$266.96M-0.95330News CoverageUpcoming EarningsHigh Trading VolumePLXProtalix BioTherapeutics2.2289 of 5 stars$1.50-0.7%$15.00+900.0%+36.2%$119.41M$59.76M-11.54200News CoverageGap UpCRDLCardiol Therapeutics1.9541 of 5 stars$1.53+6.3%$8.00+422.9%-33.7%$119.02MN/A-4.5020Gap UpHigh Trading VolumeSAVACassava Sciences3.5959 of 5 stars$2.38+1.3%$54.50+2,189.9%-91.0%$113.52MN/A-1.5930CRBPCorbus Pharmaceuticals4.7358 of 5 stars$9.59+3.6%$50.88+430.5%-84.2%$113.31MN/A-2.2740News CoverageUpcoming EarningsAnalyst ForecastAnalyst RevisionHigh Trading VolumeZURAZura Bio3.6303 of 5 stars$1.62-1.2%$14.33+784.8%-60.1%$112.14MN/A-2.313News CoveragePositive News Related Companies and Tools Related Companies ALTS Alternatives CNTB Alternatives FTLF Alternatives SKYE Alternatives CHRS Alternatives PLX Alternatives CRDL Alternatives SAVA Alternatives CRBP Alternatives ZURA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GBIO) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Generation Bio Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Generation Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GBIO Stock Alerts